Literature DB >> 1491127

Hypercalcemia associated with dysregulation of 1,25-dihydroxyvitamin D in arthritis.

J L Shaker1, G E Auger, P P Wendt, J W Findling.   

Abstract

We describe an elderly man who presented with hypercalcemia associated with suppressed intact parathyroid hormone (PTH) levels. Despite renal insufficiency the circulating 1,25-dihydroxyvitamin D (1,25(OH)2D) was in the upper part of the normal range. Known causes of hypercalcemia were absent and mild hypercalcemia with suppression of intact PTH persisted until after bilateral hip replacement for severe arthritis (1 year after presentation). After hip replacement the ionized calcium normalized, intact PTH normalized, and 1,25(OH)2D decreased markedly. We believe the abnormalities in mineral homeostasis were related to production of 1,25(OH)2D by inflammatory mononuclear cells associated with arthritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491127     DOI: 10.1007/BF03347650

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.

Authors:  N A Breslau; J L McGuire; J E Zerwekh; E P Frenkel; C Y Pak
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

2.  Hypercalcemia associated with silicone-induced granulomas.

Authors:  G A Kozeny; A L Barbato; V K Bansal; L L Vertuno; J E Hano
Journal:  N Engl J Med       Date:  1984-10-25       Impact factor: 91.245

3.  Hypercalcemia in disseminated candidiasis.

Authors:  H M Kantarjian; M F Saad; E H Estey; R V Sellin; N A Samaan
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

4.  Hypercalcemia with excess serum 1,25 dihydroxyvitamin D in lymphomatoid granulomatosis/angiocentric lymphoma.

Authors:  S J Scheinman; M W Kelberman; A H Tatum; K W Zamkoff
Journal:  Am J Med Sci       Date:  1991-03       Impact factor: 2.378

5.  Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism.

Authors:  R Miura; S Yumita; K Yoshinaga; Y Furukawa
Journal:  Calcif Tissue Int       Date:  1990-05       Impact factor: 4.333

6.  Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D.

Authors:  U Trechsel; J A Eisman; J A Fischer; J P Bonjour; H Fleisch
Journal:  Am J Physiol       Date:  1980-08

7.  Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis.

Authors:  E B Mawer; M E Hayes; P E Still; M Davies; G A Lumb; J Palit; P J Holt
Journal:  J Bone Miner Res       Date:  1991-07       Impact factor: 6.741

8.  Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat.

Authors:  D A Bushinsky; G S Riera; M J Favus; F L Coe
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism.

Authors:  H N Hulter; B P Halloran; R D Toto; J C Peterson
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Peritonitis induces the synthesis of 1 alpha,25-dihydroxyvitamin D3 in macrophages from CAPD patients.

Authors:  M E Hayes; D J O'Donoghue; F W Ballardie; E B Mawer
Journal:  FEBS Lett       Date:  1987-08-17       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.